一贯煎加减联合西医常规方案治疗肝硬化腹水 疗效和安全性的系统评价.

OBJECTIVE: To systematically evaluate the efficacy and safety of Yiguanjian decoction combined with conventional western medicine in the treatment of ascites induced by liver cirrhosis. METHODS: CNKI, VIP, Wanfang Data, Embase, Web of science, PubMed and Clinical Trials databases were retrieved to collect randomized controlled trials that met the screening criteria (the control group received conventional western medicine, while the observation group received Yiguanjian decoction on the basis of control group ), the search time was from the establishment of the database until Feb. 2023. The Cochrane Collaboration Network bias risk assessment was used for quality assessment, and Meta-analysis was performed by using RevMan 5. 4 software. RESULTS: Totally 15 articles were enrolled, including 1 147 patients. Meta-analysis showed that compared with the control group, the treatment regimen in the observation group could improve the total effective rate (RR = 1. 31,95%CI = 1. 24-1. 40,P<0. 000 01) and reduce abdominal circumference (MD = - 8. 26,95% CI = - 10. 44-- 6. 09,P < 0. 000 01), decrease body mass (MD= -6. 86,95%CI = -8. 23--5. 48,P<0. 000 01), increase 24 h urine volume (MD = 465. 38,95%CI = 351. 27- 579. 48,P<0. 000 01), and shorten disappearance time of ascites (MD= -7. 29,95%CI = -13. 97--0. 61,P = 0. 03), and improve liver function. Meanwhile, the incidence of adverse drug reactions in the observation group decreased. CONCLUSIONS: Yiguanjian decoction can improve the efficacy of conventional western medicine treatment of cirrhotic ascites, with few adverse drug reactions. [ABSTRACT FROM AUTHOR]